PATENT CLAIM ANALYSIS

Application Number: 15767945
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "064000"]

Abstract:
The present invention provides a urea peptidomimetic boronic compound and pharmaceutical compositions thereof, their preparative methods and uses. The compounds are represented by the following formula (1).

Claim (Index 15):
A method of inhibiting a cancer comprising:\n administrating the compound or a pharmaceutically acceptable salt or solvate thereof according to  claim 1  to a subject that has cancer.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.10345
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13379142', '16300162', '14567480', '14734233', '13582678']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7101069654735459
- 35 USC 102 Novelty (BERT): 0.5141680808506096
- Combined Prediction Score: 0.6905130770112523
- Mean Citation Score: 214.68997
- Max Citation Score: 237.31741
- Similarity Product: 147.6516530463409

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test